Orchard acquires GSK’s gene therapy portfolio

13-04-2018

Orchard acquires GSK’s gene therapy portfolio

vchal / iStockphoto.com

Orchard Therapeutics has acquired GSK’s gene therapy portfolio, in an agreement intended to advance Orchard’s work in the field of rare diseases and allow GSK to focus on oncology.


GSK, Orchard Therapeutics, Ospedale San Raffaele, Fondazione Telethon, MolMed

LSIPR